Table 1.
Total (n = 42) |
HIV (n = 27) |
Non HIV (n = 15) |
p | |
---|---|---|---|---|
Age (median; IQR) | 40; 16 (35–51) | 45; 16 (36–52) | 37: 18 (32–50) | NS |
Origin (n; %) | NS | |||
Spanish | 18 (43%) | 10/18 | 8/18 | |
Foreign | 24 (57%) | 17/24 | 7/24 | |
Europe | 14 | 9 | 5 | |
Germany | 3 | 3 | 0 | |
France | 1 | 0 | 1 | |
United Kingdom | 1 | 0 | 1 | |
Italy | 3 | 3 | 0 | |
Poland | 3 | 1 | 2 | |
Portugal | 1 | 1 | 0 | |
Russia | 1 | 0 | 1 | |
Switzerland | 1 | 1 | 0 | |
Latin America | 9 | 8 | 1 | |
Argentina | 1 | 1 | 0 | |
Brazil | 1 | 1 | 0 | |
Colombia | 1 | 1 | 0 | |
Cuba | 3 | 3 | 0 | |
Honduras | 1 | 1 | 0 | |
Peru | 1 | 1 | 0 | |
Dominican Republic | 1 | 0 | 1 | |
Africa | 1 | 0 | 1 | |
Morocco | 1 | 0 | 1 | |
Fever (n; %) | 15 (36%) | 8/15 | 7/15 | NS |
Lymphadenopathies (n; %) | 17 (40%) | 10/17 | 7/17 | NS |
Cervical | 7 (17%) | 4/7 | 3/7 | |
Inguinal | 10 (24%) | 6/7 | 4/7 | |
Skin and mucosal lessions | 42 | |||
Head and neck (n; %) | 25 (60%) | 17/25 | 8/25 | 0.01 |
Perioral | 15 | 12/15 | 3/15 | |
Other | 10 | 3/10 | 7/10 | |
Trunk (n; %) | 20 (48%) | 13/20 | 7/25 | NS |
Abdomen/Buttocks (n; %) | 19 (45%) | 12/19 | 7/19 | NS |
Genital lesions (n; %) | 22 (52%) | 15/21 | 7/21 | NS |
Perianal (n; %) | 6 (14%) | 3/6 | 3/6 | NS |
Limbs (n; %) | 30 (71%) | 17/29 | 13/19 | NS |
Arms | 14 | 7/14 | 7/14 | |
Legs | 3 | 3/3 | 0/3 | |
Both | 13 | 7/13 | 6/13 | |
Pharyngitis (n; %) | 7 (17%) | 7/7 | 0/7 | 0.03 |
Proctitis (n; %) | 5 (12%) | 3/5 | 2/5 | NS |
Penis and or scrotal edema (n; %) | 5 (12%) | 3/5 | 2/5 | NS |
Local complications (n; %) | 2 (5%) | 1/2 Severe dysphagia |
1/2 Urinary retention |
NS |
Other infectious diseases (n; %) | 11/24 * (50%) | 10/11 | 1/11 | 0.03 |
Chlamydia trachomatis | 1 | 0 | ||
Haemophilus parainfluenzae | 1 | 0 | ||
Herpesvirus type 2 | 1 | 0 | ||
MS Staphylococcus aureus | 1 | 0 | ||
Mycoplasma genitalium | 2 | 0 | ||
Mycoplasma hominis | 1 | 1 | ||
Pantoea septica | 1 | 0 | ||
Streptococcus dysgalactiae (1) | 1 | 0 | ||
Ureaplasma urealyticum (4) | 4 | 0 |
* Three patients have more than one microorganism.